Johannes Bacher
Net Worth
Last updated:
What is Johannes Bacher net worth?
The estimated net worth of Mr. Johannes Bacher is at least $1,582,000 as of 31 Mar 2023. He owns shares worth $282,000 as insider and has received compensation worth at least $1,300,000 in OpGen, Inc..
What is the salary of Johannes Bacher?
Mr. Johannes Bacher salary is $325,000 per year as Chief Operating Officer in OpGen, Inc..
How old is Johannes Bacher?
Mr. Johannes Bacher is 56 years old, born in 1969.
What stocks does Johannes Bacher currently own?
As insider, Mr. Johannes Bacher owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| OpGen, Inc. (OPGN) | Chief Operating Officer | 60,000 | $4.7 | $282,000 |
What does OpGen, Inc. do?
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
Johannes Bacher insider trading
OpGen, Inc.
OpGen key executives
OpGen, Inc. executives and other stock owners filed with the SEC:
- Dr. Oliver Schacht Ph.D. (54) Chief Executive Officer, Pres & Director
- Mr. Johannes Bacher (56) Chief Operating Officer